Skip to main navigation Skip to search Skip to main content

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

  • Manuela Gambella
  • , Alberto Rocci
  • , Roberto Passera
  • , Francesca Gay
  • , Paola Omedè
  • , Claudia Crippa
  • , Paolo Corradini
  • , Alessandra Romano
  • , Davide Rossi
  • , Marco Ladetto
  • , Mario Boccadoro
  • , Antonio Palumbo

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e14-e16
JournalHaematologica
Volume99
Issue number2
DOIs
Publication statusPublished - 1 Feb 2014
Externally publishedYes

Keywords

  • BLIMP1
  • Bortezomib
  • IRF4
  • Multiple myeloma biomarker
  • XBP1

Cite this